Morpho, Inc.

As of April 30, 2026, Morpho, Inc. carries a market capitalization of 3.36B, placing it among publicly traded companies globally. Its enterprise value stands at 1.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Morpho, Inc.'s next confirmed earnings release is scheduled for December 11, 2026.

As of April 30, 2026, Morpho, Inc. has 5.16M shares outstanding.

These figures are as of April 30, 2026.

As of April 30, 2026, Morpho, Inc. maintains a current ratio of 5.78, meaning it holds 5.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended April 30, 2026.

As of the close on October 22, 2026, Morpho, Inc.'s stock has declined approximately 13.06% over the past 52 weeks. The 50-day moving average sits at 962.56, while the 200-day moving average is 767.75.

These figures are as of April 30, 2026. Total book value stands at 2.95B, with working capital of 2.15B providing operational flexibility.

Morpho, Inc.'s most recent stock split took place on April 27, 2015 with a 1:3 split ratio.